Accuracy of biopsy gleason scores uropathology laboratory: Use of protocol to minimize observer

Urology

Volumn 51, Issue 4, 1998, Pages 525-529

  Carlson, Grant D ^a   Calvanese, Christina B ^b   Kahane, Hillel ^b   Epstein, Jonathan I ^b  

^a Dianon Systems   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL PROTOCOL; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; BIOPSY; CLINICAL PROTOCOLS; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 0031947317     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00002-8     Document Type: Article

References (22)

1. Kojima M, Troncoso P, and Babaian RJ: Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error. Urology 45: 807-812, 1995.
2. Babaian RJ, and Grunow WA: Reliability of Gleason grading system in comparing prostate biopsies with total prostatectomy specimens. Urology 25: 564-567, 1985.
3. Thickman D, Speers WC, Philpott PJ, and Shapiro H: Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J Urol 156:110-113, 1996.
4. Cookson MS, Fleshner NE, Soloway SM, and Fair WR: Correlation between Gleason score of needle biopsy and radical prostatectomy specimens: accuracy and clinical implications. J Urol 157: 559-562, 1997.
5. Lange PH, and Narayan P: Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy. Urology 21: 113-118, 1983.
6. Garnett JE, Oyasu R, and Grayhack JT: The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens. J Urol 131: 690-693, 1984.
7. Mills SE, and Fowler JE Jr: Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens. Cancer 57: 346-349, 1986.
8. Spires SE, Cibull ML, Wood DP Jr, Miller S, Spires SM, and Banks ER: Gleason histologic grading in prostatic carcinoma: correlation of 18-gauge core biopsy with prostatectomy. Arch Pathol Lab Med 118: 705-708, 1994.
9. Steinberg DM, Sauvageot J, Piantadosi S, and Epstein JI: Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21: 566-576, 1997.
10. Gleason DF: Classification of prostate carcinomas. Cancer Chemother Rep 50: 125-128, 1966.
11. Kahane H, Sharp JW, Shuman GB, Dasilva G, and Epstein JI: Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory. Urology 45: 981-986, 1995.
12. Partin AW, Yoo J, Carter BH, Pearson JD, Chan DW, Epstein JI, and Walsh PC: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150: 110-114, 1993.
13. Epstein JI, Pizov G, and Walsh PC: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71: 3582-3593, 1993.
14. Zagars GK, Pollack A, and von Eschenbach AC: Prognostic factors for clinically localized prostate carcinoma; analysis of 938 patients irradiated in the prostate specific antigen era. Cancer 79: 1370-1380, 1997.
15. Coetzee LJ, Layfield LJ, Hard V, and Paulson DF: Proliferative index determination in prognostic carcinoma tissue: is there any additional prognostic value greater than that of Gleason score, ploidy and pathologic stage? J Urol 157: 214-218, 1996.
16. Stone NN, Stock RG, and Unger P: Indications for seminal vesicle biopsy and laproscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol 154: 1392-1396, 1995.
17. Oesterling JE, Brendler CB, Epstein JI, Kimball AW, and Walsh PC: Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138: 92-98, 1987.
18. Narayan P, Jajodia P, Stein R, and Tanagho EA: A comparison of fine needle aspiration and core biopsy in diagnosis and preoperative grading of prostate cancer. J Urol 141: 560-563, 1989.
19. Ackerman DA, Barry JM, Wicklund RA, Olson N, and Lowe B: Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic lymph node metastasis at radical prostatectomy. J Urol 150: 1845-1850, 1993.
20. Bostwick DG: Grading prostate cancer. Am J Clin Pathol 102(4 suppl 1): S38-S56, 1994.
21. Di Loreto C, Fitzpatrick B, Underhill S, Kim DH, Dytch HE, Galera-Davidson H, and Bibbo M: Correlation between visual clues, objective architectural features, and inter-observer agreement in prostate cancer. Am J Clin Pathol 96: 70-75, 1991.
22. Gleason DF: Histologic grading of prostate cancer: a prospective. Hum Pathol 23: 273-279, 1992.